Influenza Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The global influenza diagnostics market size reached US$ 893.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,461.7 Million by 2028, exhibiting a growth rate (CAGR) of 6.55% during 2023-2028.
Influenza, or flu, refers to a viral infection that mainly affects the human respiratory system, including the nose, throat, and lungs. Influenza diagnostics includes numerous immunoassay tests that aid in detecting the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens. Some of the commonly available diagnostic tests include rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, serology, and rapid molecular assays. Healthcare facilities can assess the precision of these tests by looking at their sensitivity and specificity, which are crucial factors that determine their accuracy levels.
Influenza Diagnostics Market Trends:
The elevating prevalence of several chronic diseases, such as asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis, etc., that increase the risk of influenza, is primarily driving the global influenza diagnostics market. Besides this, the expanding geriatric population, who are more prone to respiratory tract infections, is also catalyzing the market growth. Additionally, the rising availability of advanced diagnostic immunoassay formats along with the growing usage of miniaturized devices in influenza diagnostics is positively influencing the global market. Moreover, the introduction of CLIA-waived POC molecular influenza tests and the shifting consumer preferences from centralized laboratories to decentralized point-of-care testing are also augmenting the market growth. In addition to this, the emerging popularity of rapid influenza diagnostic test (RIDT) that are convenient to use and provide results in approximately fifteen minutes is acting as a significant growth-inducing factor. Furthermore, various initiatives by WHO to strengthen influenza surveillance, monitoring, and data utilization, are also stimulating the market growth. In line with this, numerous government bodies are becoming more actively involved in taking preventative steps to reduce the risk of influenza. For instance, the U.S. CDC and the South-East Asian Region (SEAR) have collaborated to support non-researched bilateral influenza as a response to avian, seasonal, and pandemic influenza. In the coming years, the growing integration of artificial intelligence (AI) in influenza diagnostics to minimize the timelines for sample processing and facilitate error-free results is expected to drive the global influenza diagnostics market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global influenza diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, test type, type of flu and end user.
Breakup by Product:
Test Kit and Reagents
Instruments
Others
Breakup by Test Type:
Molecular Diagnostic Tests
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Tests
Other Molecular Tests
Traditional Diagnostic Tests
Rapid Influenza Diagnostic Tests
Viral Culture Tests
Direct Fluorescent Antibody Test
Serological Tests
Breakup by Type of Flu:
Type A Flu
Type B Flu
Type C Flu
Breakup by End User:
Hospitals
Diagnostic Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Coris Bioconcept, Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd (Roche Holding AG), Hologic Inc., Meridian Bioscience Inc., Qiagen N.V, Quidel Corporation, Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.) and Siemens Healthineers AG (Siemens AG).
Key Questions Answered in This Report
1. What was the size of the global influenza diagnostics market in 2022?
2. What is the expected growth rate of the global influenza diagnostics market during 2023-2028?
3. What are the key factors driving the global influenza diagnostics market?
4. What has been the impact of COVID-19 on the global influenza diagnostics market?
5. What is the breakup of the global influenza diagnostics market based on the product?
6. What is the breakup of the global influenza diagnostics market based on the test type?
7. What is the breakup of the global influenza diagnostics market based on type of flu?
8. What is the breakup of the global influenza diagnostics market based on the end user?
9. What are the key regions in the global influenza diagnostics market?
10. Who are the key players/companies in the global influenza diagnostics market?
Influenza, or flu, refers to a viral infection that mainly affects the human respiratory system, including the nose, throat, and lungs. Influenza diagnostics includes numerous immunoassay tests that aid in detecting the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens. Some of the commonly available diagnostic tests include rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, serology, and rapid molecular assays. Healthcare facilities can assess the precision of these tests by looking at their sensitivity and specificity, which are crucial factors that determine their accuracy levels.
Influenza Diagnostics Market Trends:
The elevating prevalence of several chronic diseases, such as asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis, etc., that increase the risk of influenza, is primarily driving the global influenza diagnostics market. Besides this, the expanding geriatric population, who are more prone to respiratory tract infections, is also catalyzing the market growth. Additionally, the rising availability of advanced diagnostic immunoassay formats along with the growing usage of miniaturized devices in influenza diagnostics is positively influencing the global market. Moreover, the introduction of CLIA-waived POC molecular influenza tests and the shifting consumer preferences from centralized laboratories to decentralized point-of-care testing are also augmenting the market growth. In addition to this, the emerging popularity of rapid influenza diagnostic test (RIDT) that are convenient to use and provide results in approximately fifteen minutes is acting as a significant growth-inducing factor. Furthermore, various initiatives by WHO to strengthen influenza surveillance, monitoring, and data utilization, are also stimulating the market growth. In line with this, numerous government bodies are becoming more actively involved in taking preventative steps to reduce the risk of influenza. For instance, the U.S. CDC and the South-East Asian Region (SEAR) have collaborated to support non-researched bilateral influenza as a response to avian, seasonal, and pandemic influenza. In the coming years, the growing integration of artificial intelligence (AI) in influenza diagnostics to minimize the timelines for sample processing and facilitate error-free results is expected to drive the global influenza diagnostics market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global influenza diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, test type, type of flu and end user.
Breakup by Product:
Test Kit and Reagents
Instruments
Others
Breakup by Test Type:
Molecular Diagnostic Tests
Polymerase Chain Reaction
Isothermal Nucleic Acid Amplification Tests
Other Molecular Tests
Traditional Diagnostic Tests
Rapid Influenza Diagnostic Tests
Viral Culture Tests
Direct Fluorescent Antibody Test
Serological Tests
Breakup by Type of Flu:
Type A Flu
Type B Flu
Type C Flu
Breakup by End User:
Hospitals
Diagnostic Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Coris Bioconcept, Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd (Roche Holding AG), Hologic Inc., Meridian Bioscience Inc., Qiagen N.V, Quidel Corporation, Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.) and Siemens Healthineers AG (Siemens AG).
Key Questions Answered in This Report
1. What was the size of the global influenza diagnostics market in 2022?
2. What is the expected growth rate of the global influenza diagnostics market during 2023-2028?
3. What are the key factors driving the global influenza diagnostics market?
4. What has been the impact of COVID-19 on the global influenza diagnostics market?
5. What is the breakup of the global influenza diagnostics market based on the product?
6. What is the breakup of the global influenza diagnostics market based on the test type?
7. What is the breakup of the global influenza diagnostics market based on type of flu?
8. What is the breakup of the global influenza diagnostics market based on the end user?
9. What are the key regions in the global influenza diagnostics market?
10. Who are the key players/companies in the global influenza diagnostics market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL INFLUENZA DIAGNOSTICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Test Kit and Reagents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY TEST TYPE
7.1 Molecular Diagnostic Tests
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Polymerase Chain Reaction
7.1.2.2 Isothermal Nucleic Acid Amplification Tests
7.1.2.3 Other Molecular Tests
7.1.3 Market Forecast
7.2 Traditional Diagnostic Tests
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Rapid Influenza Diagnostic Tests
7.2.2.2 Viral Culture Tests
7.2.2.3 Direct Fluorescent Antibody Test
7.2.2.4 Serological Tests
7.2.3 Market Forecast
8 MARKET BREAKUP BY TYPE OF FLU
8.1 Type A Flu
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Type B Flu
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Type C Flu
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Diagnostic Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Becton Dickinson and Company
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Coris Bioconcept
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Danaher Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 DiaSorin S.p.A.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 F. Hoffmann-La Roche Ltd (Roche Holding AG)
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 SWOT Analysis
15.3.7 Hologic Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Meridian Bioscience Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Qiagen N.V
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Quidel Corporation
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.)
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 Siemens Healthineers AG (Siemens AG)
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL INFLUENZA DIAGNOSTICS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Test Kit and Reagents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY TEST TYPE
7.1 Molecular Diagnostic Tests
7.1.1 Market Trends
7.1.2 Key Segments
7.1.2.1 Polymerase Chain Reaction
7.1.2.2 Isothermal Nucleic Acid Amplification Tests
7.1.2.3 Other Molecular Tests
7.1.3 Market Forecast
7.2 Traditional Diagnostic Tests
7.2.1 Market Trends
7.2.2 Key Segments
7.2.2.1 Rapid Influenza Diagnostic Tests
7.2.2.2 Viral Culture Tests
7.2.2.3 Direct Fluorescent Antibody Test
7.2.2.4 Serological Tests
7.2.3 Market Forecast
8 MARKET BREAKUP BY TYPE OF FLU
8.1 Type A Flu
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Type B Flu
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Type C Flu
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY END USER
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Diagnostic Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast
10 MARKET BREAKUP BY REGION
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT ANALYSIS
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 VALUE CHAIN ANALYSIS
13 PORTERS FIVE FORCES ANALYSIS
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 PRICE ANALYSIS
15 COMPETITIVE LANDSCAPE
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Becton Dickinson and Company
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Coris Bioconcept
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Danaher Corporation
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 DiaSorin S.p.A.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 F. Hoffmann-La Roche Ltd (Roche Holding AG)
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 SWOT Analysis
15.3.7 Hologic Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Meridian Bioscience Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Qiagen N.V
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Quidel Corporation
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.)
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 Siemens Healthineers AG (Siemens AG)
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Influenza Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Influenza Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Influenza Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
Table 4: Global: Influenza Diagnostics Market Forecast: Breakup by Type of Flu (in Million US$), 2023-2028
Table 5: Global: Influenza Diagnostics Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Influenza Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Influenza Diagnostics Market: Competitive Structure
Table 8: Global: Influenza Diagnostics Market: Key Players
Table 1: Global: Influenza Diagnostics Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Influenza Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Influenza Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
Table 4: Global: Influenza Diagnostics Market Forecast: Breakup by Type of Flu (in Million US$), 2023-2028
Table 5: Global: Influenza Diagnostics Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: Influenza Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: Influenza Diagnostics Market: Competitive Structure
Table 8: Global: Influenza Diagnostics Market: Key Players
LIST OF FIGURES
Figure 1: Global: Influenza Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Influenza Diagnostics Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Influenza Diagnostics Market: Breakup by Product (in %), 2022
Figure 5: Global: Influenza Diagnostics Market: Breakup by Test Type (in %), 2022
Figure 6: Global: Influenza Diagnostics Market: Breakup by Type of Flu (in %), 2022
Figure 7: Global: Influenza Diagnostics Market: Breakup by End User (in %), 2022
Figure 8: Global: Influenza Diagnostics Market: Breakup by Region (in %), 2022
Figure 9: Global: Influenza Diagnostics (Test Kit and Reagents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Influenza Diagnostics (Test Kit and Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Influenza Diagnostics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Influenza Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Influenza Diagnostics (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Influenza Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Influenza Diagnostics (Type A Flu) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Influenza Diagnostics (Type A Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Influenza Diagnostics (Type B Flu) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Influenza Diagnostics (Type B Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Influenza Diagnostics (Type C Flu) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Influenza Diagnostics (Type C Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Influenza Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Influenza Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Influenza Diagnostics (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Influenza Diagnostics (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Influenza Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Influenza Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: North America: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: North America: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: United States: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: United States: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Canada: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Canada: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Asia-Pacific: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Asia-Pacific: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: China: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: China: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Japan: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Japan: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: India: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: India: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: South Korea: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: South Korea: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Australia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Australia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Indonesia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Indonesia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Europe: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Europe: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Germany: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Germany: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: France: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: France: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: United Kingdom: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: United Kingdom: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Italy: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Italy: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Spain: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Spain: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Russia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Russia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Latin America: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Latin America: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Brazil: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Brazil: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Mexico: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Mexico: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Middle East and Africa: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Middle East and Africa: Influenza Diagnostics Market: Breakup by Country (in %), 2022
Figure 79: Middle East and Africa: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Global: Influenza Diagnostics Industry: SWOT Analysis
Figure 81: Global: Influenza Diagnostics Industry: Value Chain Analysis
Figure 82: Global: Influenza Diagnostics Industry: Porter's Five Forces Analysis
Figure 1: Global: Influenza Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Influenza Diagnostics Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Influenza Diagnostics Market: Breakup by Product (in %), 2022
Figure 5: Global: Influenza Diagnostics Market: Breakup by Test Type (in %), 2022
Figure 6: Global: Influenza Diagnostics Market: Breakup by Type of Flu (in %), 2022
Figure 7: Global: Influenza Diagnostics Market: Breakup by End User (in %), 2022
Figure 8: Global: Influenza Diagnostics Market: Breakup by Region (in %), 2022
Figure 9: Global: Influenza Diagnostics (Test Kit and Reagents) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Influenza Diagnostics (Test Kit and Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Influenza Diagnostics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Influenza Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Influenza Diagnostics (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Influenza Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Influenza Diagnostics (Type A Flu) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Influenza Diagnostics (Type A Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Influenza Diagnostics (Type B Flu) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Influenza Diagnostics (Type B Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Influenza Diagnostics (Type C Flu) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Influenza Diagnostics (Type C Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Influenza Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Influenza Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Influenza Diagnostics (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Influenza Diagnostics (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Influenza Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Influenza Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: North America: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: North America: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: United States: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: United States: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Canada: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Canada: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Asia-Pacific: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Asia-Pacific: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: China: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: China: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Japan: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Japan: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: India: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: India: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: South Korea: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: South Korea: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Australia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Australia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Indonesia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Indonesia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Europe: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Europe: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Germany: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Germany: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: France: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: France: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: United Kingdom: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: United Kingdom: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Italy: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Italy: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Spain: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Spain: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Russia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Russia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Latin America: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Latin America: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Brazil: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Brazil: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Mexico: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Mexico: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Middle East and Africa: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Middle East and Africa: Influenza Diagnostics Market: Breakup by Country (in %), 2022
Figure 79: Middle East and Africa: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Global: Influenza Diagnostics Industry: SWOT Analysis
Figure 81: Global: Influenza Diagnostics Industry: Value Chain Analysis
Figure 82: Global: Influenza Diagnostics Industry: Porter's Five Forces Analysis
